What is Vericel?
Vericel Corporation, formerly Aastrom Biosciences, Inc., is a biopharmaceutical firm established in 1989 and headquartered in Cambridge, Massachusetts. The company specializes in the development, manufacturing, and commercialization of innovative cell therapies and specialty biologic products. Vericel primarily targets the sports medicine and severe burn care markets within North America. Its product portfolio includes autologous cell therapy solutions and a licensed specialty biologic for burn treatment, distributed through orthopedic surgeons, sports medicine specialists, and dedicated burn care centers. The company leverages advancements in cell biology and medical technology to offer differentiated therapies aimed at injury repair and addressing critical medical conditions.
How much funding has Vericel raised?
Vericel has raised a total of $313.8M across 14 funding rounds:
Stock Offering
$12.4M
Stock Offering
$20.5M
Share Placement
$38M
Stock Offering
$9M
Private Equity
$15M
Stock Offering
$40.3M
Stock Offering
$20M
Debt
$25M
Stock Offering
$74.8M
Stock Issuance/Offering (2010): $12.4M with participation from Undisclosed
Stock Issuance/Offering (2010): $20.5M led by Undisclosed
Share Placement (2012): $38M supported by Eastern Capital
Stock Issuance/Offering (2013): $9M featuring Undisclosed
Private Equity (2014): $15M backed by Lincoln Park Capital
Stock Issuance/Offering (2014): $40.3M with participation from Undisclosed
Stock Issuance/Offering (2016): $20M led by Undisclosed
Debt (2017): $25M supported by Silicon Valley Bank and MidCap Financial
Stock Issuance/Offering (2018): $74.8M featuring Undisclosed
Key Investors in Vericel
Silicon Valley Bank
Silicon Valley Bank (SVB) is a commercial and private banking institution founded in 1983, offering a comprehensive suite of financial services including asset management, wealth management, brokerage, and investment services. SVB is known for its focus on the technology and life sciences sectors.
MidCap Financial
MidCap Financial is a lending institution that provides tailored and flexible financing solutions, emphasizing speed and efficiency. They specialize in addressing business opportunities with timely capital, aiming to support growth and operational needs.
Lincoln Park Capital
Lincoln Park Capital is an investment group and asset management firm based in Chicago, specializing in opportunistic investments across public and private companies and real estate. They focus on growth and partnership opportunities through various investment strategies.
What's next for Vericel?
The recent major strategic investment in Vericel signals a pivotal phase for the company, likely enabling accelerated development and commercialization of its advanced cell therapies. This capital infusion is expected to bolster its market presence in sports medicine and severe burn care, potentially expanding its reach and enhancing its product pipeline. Vericel's focus on innovative cell biology and medical technology positions it for continued growth and leadership in regenerative medicine.
See full Vericel company page
